Richard B Markham Selected Research

A-Form DNA (A-DNA)

1/2020	Antibiotic Treatment Shapes the Antigenic Environment During Chronic TB Infection, Offering Novel Targets for Therapeutic Vaccination.
1/2016	Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard B Markham Research Topics

Disease

5	Infections 01/2020 - 06/2009
4	Neoplasms (Cancer) 04/2020 - 01/2014
3	Malaria 01/2021 - 01/2014
3	Melanoma (Melanoma, Malignant) 04/2020 - 01/2016
1	Tuberculosis (Tuberculoses) 01/2020
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2015
1	Sepsis (Septicemia) 01/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2005

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 01/2021 - 01/2014
4	DNA VaccinesIBA 04/2020 - 01/2014
3	ChemokinesIBA 01/2021 - 01/2014
3	AntigensIBA 04/2020 - 01/2014
3	Pharmaceutical PreparationsIBA 01/2020 - 06/2009
2	A-Form DNA (A-DNA)IBA 01/2020 - 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2020
1	Interferon Type IIBA 05/2018
1	Interleukin-10 (Interleukin 10)IBA 05/2018
1	Neutralizing AntibodiesIBA 05/2018
1	N,N,N',N'- tetrakis(2- pyridylmethyl)ethylenediamineIBA 01/2017
1	Chelating AgentsIBA 01/2017
1	ZincIBA 01/2017
1	gp100 Melanoma AntigenIBA 01/2016
1	Cancer VaccinesIBA 01/2016
1	Anti-Infective Agents (Microbicides)IBA 01/2015
1	EnzymesIBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2014
1	CytokinesIBA 01/2014
1	LipidsIBA 01/2014
1	pevonedistatIBA 01/2014
1	vaxfectinIBA 01/2014
1	Subunit VaccinesIBA 01/2014
1	Local Anti-Infective Agents (Antiseptics)IBA 09/2005

Therapy/Procedure

2	Therapeutics 05/2018 - 01/2016
1	Transplantation 04/2020
1	Immunotherapy 01/2016